Parkinson's disease in a dish – Using stem cells as a molecular tool
Authors:
- O. Cordero-LlanaOCO. Cordero-Llana
- E.M. HartfieldEHE.M. Hartfield
- R. Wade-MartinsRWR. Wade-Martins
- 1 January 2014
- journal article
- review article
- Published by Elsevier in Neuropharmacology
- Vol. 76, 88-96
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Living on the edge with too many mouths to feed: Why dopamine neurons dieMovement Disorders, 2012
- Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's diseaseEMBO Molecular Medicine, 2012
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in SynucleinopathiesCell, 2011
- LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative StressCell Stem Cell, 2011
- Differentiation of human ES and Parkinson's disease iPS cells into ventral midbrain dopaminergic neurons requires a high activity form of SHH, FGF8a and specific regionalization by retinoic acidMolecular and Cellular Neuroscience, 2010
- Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after EndocytosisNeuron, 2010
- Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem Cells2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003